191 related items for PubMed ID: 4093243
1. Cyclophosphamide therapy in frequently relapsing nephrotic syndrome with and without steroid dependence.
Srivastava RN, Agarwal RK, Choudhry VP, Moudgil A, Bhuyan UN, Sunderam KR.
Int J Pediatr Nephrol; 1985; 6(4):245-50. PubMed ID: 4093243
[Abstract] [Full Text] [Related]
2. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
Kyrieleis HA, Levtchenko EN, Wetzels JF.
Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
[Abstract] [Full Text] [Related]
3. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano R, Lama G, Zacchello G, Confalonieri R, Altieri P.
Nephrol Dial Transplant; 1993 May; 8(12):1326-32. PubMed ID: 8159300
[Abstract] [Full Text] [Related]
4. Long-term follow-up of patients with steroid-dependent, minimal change nephrotic syndrome.
Kashtan C, Melvin T, Kim Y.
Clin Nephrol; 1988 Feb; 29(2):79-85. PubMed ID: 3359697
[Abstract] [Full Text] [Related]
5. Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide.
Bailey RR.
N Z Med J; 1989 Jul 26; 102(872):379-81. PubMed ID: 2797556
[Abstract] [Full Text] [Related]
6. Spontaneous remissions in frequently relapsing and steroid dependent idiopathic nephrotic syndrome.
Wingen AM, Müller-Wiefel DE, Schärer K.
Clin Nephrol; 1985 Jan 26; 23(1):35-40. PubMed ID: 3978880
[Abstract] [Full Text] [Related]
7. Chlorambucil treatment of frequently relapsing nephrotic syndrome.
Grupe WE, Makker SP, Ingelfinger JR.
N Engl J Med; 1976 Sep 30; 295(14):746-9. PubMed ID: 958261
[Abstract] [Full Text] [Related]
8. Long-term effects of cyclophosphamide therapy in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.
Cammas B, Harambat J, Bertholet-Thomas A, Bouissou F, Morin D, Guigonis V, Bendeddouche S, Afroukh-Hacini N, Cochat P, Llanas B, Decramer S, Ranchin B.
Nephrol Dial Transplant; 2011 Jan 30; 26(1):178-84. PubMed ID: 20610527
[Abstract] [Full Text] [Related]
9. Cyclosporin A plus prednisone treatment of steroid-sensitive frequently relapsing nephrotic syndrome in children.
Aksu N, Türker M, Erdoğan H, Ozinel S, Kansoy S.
Turk J Pediatr; 1999 Jan 30; 41(2):225-30. PubMed ID: 10770662
[Abstract] [Full Text] [Related]
10. Adult minimal-change disease: clinical characteristics, treatment, and outcomes.
Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, D'Agati V, Appel G.
Clin J Am Soc Nephrol; 2007 May 30; 2(3):445-53. PubMed ID: 17699450
[Abstract] [Full Text] [Related]
11. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
Faedda R, Pirisi M, Satta A, Tanda F, Bartoli E.
Clin Nephrol; 1996 Oct 30; 46(4):237-44. PubMed ID: 8905208
[Abstract] [Full Text] [Related]
12. Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome.
Alsaran K, Grisaru S, Stephens D, Arbus G.
Clin Nephrol; 2001 Oct 30; 56(4):289-94. PubMed ID: 11680658
[Abstract] [Full Text] [Related]
13. Linear growth of children with nephrotic syndrome: effect of alkylating agents.
Padilla R, Brem AS.
Pediatrics; 1989 Sep 30; 84(3):495-9. PubMed ID: 2771553
[Abstract] [Full Text] [Related]
14. Mesangial proliferative glomerulonephritis in children.
Uszycka-Karcz M, Stolarczyk J, Wrzolkowa T, Kamińska H, Zurowska A, Marczak E, Schramm K, Mierzewski P.
Int J Pediatr Nephrol; 1982 Dec 30; 3(4):251-6. PubMed ID: 7166451
[Abstract] [Full Text] [Related]
15. Difficult-to-treat nephrotic syndrome: management and outcome.
Sumboonnanonda A, Chongchate N, Suntornpoch V, Pattaragarn A, Supavekin S.
J Med Assoc Thai; 2005 Nov 30; 88 Suppl 8():S142-8. PubMed ID: 16856434
[Abstract] [Full Text] [Related]
16. [Good results of cyclophosphamide in steroid toxicity in the treatment of nephrotic syndrome caused by minimal-lesion glomerulopathy in childhood].
de Moor R, de Jong M, Monnens L.
Ned Tijdschr Geneeskd; 1992 May 02; 136(18):876-80. PubMed ID: 1589052
[Abstract] [Full Text] [Related]
17. [The treatment with levamisole of frequently recurring steroid-sensitive idiopathic nephrotic syndrome in children].
Kemper MJ, Amon O, Timmermann K, Altrogge H, Müller-Wiefel DE.
Dtsch Med Wochenschr; 1998 Feb 27; 123(9):239-43. PubMed ID: 9524533
[Abstract] [Full Text] [Related]
18. [Treatment of idiopathic nephrotic syndrome with cyclosporin A].
Ariceta Iraola G, Rodríguez Soriano J, Vallo Boado A, Quintela Pérez MJ, Oliveros Pérez R.
An Esp Pediatr; 1997 Sep 27; 47(3):273-8. PubMed ID: 9499280
[Abstract] [Full Text] [Related]
19. Steroid responsiveness of children with idiopathic nephrotic syndrome in southeastern region of Turkey.
Davutoglu M, Ece A, Bilici M, Dagli A.
Ren Fail; 2007 Sep 27; 29(7):855-9. PubMed ID: 17994455
[Abstract] [Full Text] [Related]
20. Long-term evaluation of chlorambucil plus prednisone in the idiopathic nephrotic syndrome of childhood.
Williams SA, Makker SP, Ingelfinger JR, Grupe WE.
N Engl J Med; 1980 Apr 24; 302(17):929-33. PubMed ID: 6987521
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
